Latest Breaking News On - Erez aminov - Page 1 : comparemela.com

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

Ruling removes potential complications for manufacturing, pre-clinical development, IND submission, clinical development, and ultimately commercialization. MIAMI, May 29, 2024 /PRNewswire/ MIRA.

MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company's Novel Oral Ketamine Analog

Ketamir-2, the Company s novel oral ketamine analog in development, aims to provide a safe and effective alternative for managing cancer pain and associated depression MIAMI, May 21, 2024.

Mira Pharmaceuticals Advances Preclinical Trials T

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and

Mira Pharma (MIRA) Reports Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission

MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

AI Simulation on MIRA1a Showcases Significant Potential Advantages Over Plant-Based Medical Marijuana Related to Anxiety, Appetite and Cognition BALTIMORE, Dec. 4, 2023 /PRNewswire/  MIRA.